propofol has been researched along with Absence Status in 130 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of ketamine (KE) in the management of refractory convulsive status epilepticus (RSE) in children." | 9.16 | Efficacy and safety of ketamine in refractory status epilepticus in children. ( Cecchi, C; Guerrini, R; Ilvento, L; L'Erario, M; Mirabile, L; Pisano, T; Rosati, A, 2012) |
| "To assess safety and efficacy of propofol and thiopental for refractory status epilepticus (RSE) in children, the authors reviewed 34 episodes of RSE." | 9.11 | Propofol and thiopental for refractory status epilepticus in children. ( Blussé van Oud-Alblas, HJ; Braun, KP; Malingré, M; van Gestel, JP; van Nieuwenhuizen, O; Ververs, FF, 2005) |
| "To explore outcome differences between propofol and midazolam (MDL) therapy for refractory status epilepticus (RSE)." | 9.09 | Propofol and midazolam in the treatment of refractory status epilepticus. ( Bertram, EH; Bleck, TP; Prasad, A; Worrall, BB, 2001) |
| "We studied the safety and efficacy of intravenous propofol in the out-of-hospital treatment of convulsive status epilepticus (SE) in 8 patients (age 29-70 years), 4 of them with posttraumatic epilepsy." | 9.08 | Propofol in prehospital treatment of convulsive status epilepticus. ( Kuisma, M; Roine, RO, 1995) |
| "We compared propofol with high-dose barbiturates in the treatment of refractory status epilepticus (RSE) and propose a protocol for the administration of propofol in RSE in adults, correlating propofol's effect with plasma levels." | 9.08 | Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. ( Dulaney, E; Kramer, TH; O'Meeghan, R; Raps, EC; Skaar, DJ; Stecker, MM, 1998) |
| "Several studies have compared the efficacy and safety of propofol and barbiturates in the treatment of refractory status epilepticus (RSE)." | 9.01 | Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus. ( Lu, Y; Yu, Y; Yue, H; Zhang, Q, 2019) |
| " This study aims to report the first propofol-induced refractory status epilepticus (SE) in patients with BECTS after 16 years of age, and to review SE in BECTS or induced by propofol." | 9.01 | Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review. ( Lu, L; Xiao, Y; Xiong, W; Zhang, Y; Zhou, D, 2019) |
| "Propofol Infusion Syndrome (PRIS) is a rare but potentially lethal adverse reaction secondary to the continuous intravenous infusion of this drug." | 8.98 | [Propofol Infusion Syndrome in a refractory epileptic status case]. ( Ammann, R; Correa, A; Diettes, A; López, N; Riveros, R; Torres, F, 2018) |
| "To compare the efficacy, adverse effects, and short- and long-term outcomes of refractory status epilepticus (RSE) treated with one of the two anaesthetic agents, thiopental sodium or propofol." | 8.95 | Propofol versus thiopental sodium for the treatment of refractory status epilepticus. ( Kalaivani, M; Prabhakar, H, 2017) |
| "To discuss mainly the use of propofol and barbiturates in the anesthesia of refractory status epilepticus (RSE)." | 8.84 | Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. ( Kälviäinen, R; Parviainen, I; Ruokonen, E, 2007) |
| "Several guidelines recommend the use of propofol for the treatment of refractory status epilepticus." | 8.82 | Propofol in status epilepticus: little evidence, many dangers? ( Niermeijer, JM; Uiterwaal, CS; Van Donselaar, CA, 2003) |
| "New continuous infusion antiepileptic drugs (cIV-AEDs) offer alternatives to pentobarbital for the treatment of refractory status epilepticus (RSE)." | 8.81 | Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. ( Claassen, J; Emerson, RG; Hirsch, LJ; Mayer, SA, 2002) |
| "To provide a review of the proposed mechanism of action, clinical efficacy, adverse effects, and therapeutic considerations associated with the use of propofol in the management of patients with refractory status epilepticus." | 8.80 | Role of propofol in refractory status epilepticus. ( Brown, LA; Levin, GM, 1998) |
| "To compare the effect on mortality and length of hospital stay of propofol with that of sodium thiopentone for the management of dogs with status epilepticus (SE) and refractory status epilepticus (RSE)." | 8.31 | Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs. ( Alzate, D; Araos, J; Donati, PA; Espiñeira, I; Jensen, M; Pellegrino, F; Tunesi, M, 2023) |
| "This case series highlights the potential benefits of a ketamine-dexmedetomidine infusion combined with mild hypothermia for the treatment of status epilepticus refractory to GABAergic therapy in dogs suffering from idiopathic epilepsy." | 7.96 | Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy. ( D'Urso, ES; Di Cesare, F; Gioeni, D; Rabbogliatti, V; Ravasio, G, 2020) |
| "This clinical case highlights that in comatose patients as consequence of metaldehyde poisoning, a v-EEG evaluation should be perform in order to rule out the existence of NCSE." | 7.88 | Super-refractory nonconvulsive status epilepticus due to self-poisoning with metaldehyde. ( Bosque-Varela, P; Fernández-Torre, JL; Hernández-Hernández, MA; Orizaola, P; Paramio-Paz, A; Rodríguez-Borregán, JC, 2018) |
| "The aim was to describe the safety and efficacy of (S)-ketamine [(S)-KET] in a series of patients with refractory and super-refractory status epilepticus (RSE and SRSE) in a specialized neurological intensive care unit (NICU)." | 7.83 | (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study. ( Butz, K; Dobesberger, J; Höfler, J; Kalss, G; Kuchukhidze, G; Leitinger, M; Novak, H; Pilz, G; Rohracher, A; Taylor, A; Trinka, E; Zimmermann, G, 2016) |
| "Propofol infusion syndrome (PRIS), a rare complication of propofol sedation, is associated with high mortality." | 7.81 | Therapeutic plasma exchange as treatment for propofol infusion syndrome. ( Levin, PD; Levin, V; Rund, D; Sprung, CL; Weissman, C, 2015) |
| " Propofol versus thiopental sodium for the treatment ofrefractory status epilepticus." | 7.79 | Commentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’. ( Buchhalter, J; Stang, A, 2013) |
| "A case of PRIS is described in a 17-year-old female with refractory status epilepticus (RSE) who was receiving high-dose propofol for seizure control and sedation." | 7.77 | Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation. ( Al Habash, O; Boutoille, D; Bretonniere, C; Derkinderen, P; Gabillet, L; Guitton, C; Latour, P; Rigal, JC; Villers, D, 2011) |
| "To retrospectively study effect and safety of propofol treatment in adult refractory generalised tonic clonic status epilepticus." | 7.77 | Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. ( Engelsen, BA; Flaatten, H; Gilhus, NE; Power, KN, 2011) |
| "Seizures or seizure-like phenomena which are mostly convulsive have been observed during the induction, maintenance and withdrawal phases of propofol administration." | 7.77 | Propofol withdrawal seizures: non-epileptic nature of seizures in a patient with recently controlled status epilepticus. ( Abou-Khalil, B; Arain, A; Patton, T; Smithson, K; Sonmezturk, HH; Zubair, S, 2011) |
| "Here we describe a case of propofol-related infusion syndrome (PRIS) in a child with malignant refractory status epilepticus treated with partial-exchange blood transfusion (PEBT), an innovative method of resuscitation that has the potential to reduce the mortality rate associated with this syndrome." | 7.76 | Partial-exchange blood transfusion: an effective method for preventing mortality in a child with propofol infusion syndrome. ( Asuncion, A; Coquillon, P; Da-Silva, SS; Gavrilita, C; Wong, R, 2010) |
| "To describe outcome of treatment with propofol and phenobarbital for status epilepticus (SE) after portosystemic shunt (PSS) attenuation." | 7.76 | Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbital. ( Claeys, S; Daminet, S; de Rooster, H; Gommeren, K; Hamaide, A, 2010) |
| "Propofol is a sedative, anesthetic, and antiepileptic agent that is frequently used in patients with refractory status epilepticus." | 7.75 | Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. ( Hoel, R; Iyer, VN; Rabinstein, AA, 2009) |
| "Propofol is increasingly used for the treatment of status epilepticus due to the ease of use and tolerability, even if safety data from randomized clinical trials are lacking." | 7.74 | Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. ( Harris, BT; Jobst, BC; Zarovnaya, EL, 2007) |
| "To study prospectively the effects of propofol anesthesia on seizure control, hemodynamics and course of intensive care in patients with refractory status epilepticus." | 7.73 | Propofol in the treatment of refractory status epilepticus. ( Kälviäinen, R; Mervaala, E; Parviainen, I; Ruokonen, E; Uusaro, A, 2006) |
| "Propofol is used for the treatment of refractory status epilepticus." | 7.72 | Fatal propofol infusion syndrome in association with ketogenic diet. ( Baumeister, FA; Eberhardt, J; Holthausen, H; Kunkel, J; Liebhaber, GM; Oberhoffer, R; Peters, J, 2004) |
| "A short cut review was carried out to establish whether propofol is effective at stopping fitting in resistant status epilepticus." | 7.71 | Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Propofol for resistant status epilepticus. ( Carley, S; Crawford, I, 2002) |
| "Three weeks after diagnosis of nonconvulsive status epilepticus, general anesthesia was induced with propofol and titrated to burst suppression on the electroencephalogram (EEG)." | 7.70 | Treatment of refractory complex-partial status epilepticus with propofol: case report. ( Begemann, M; Rowan, AJ; Tuhrim, S, 2000) |
| " Her seizures promptly stopped after administration of propofol (3 mg/kg bolus followed by infusion of 100 micrograms/kg/min)." | 7.69 | Treatment of convulsive status epilepticus with propofol: case report. ( Harrison, AM; Lugo, RA; Schunk, JE, 1997) |
| "Two patients with status epilepticus who were resistant to conventional treatment but responded to propofol infusions are reported." | 7.68 | Propofol infusion for control of status epilepticus. ( Grant, IS; Kapadia, F; Mackenzie, SJ, 1990) |
| "Usually, TXA-associated seizures persist for a few minutes with no progression into status epilepticus." | 6.82 | Tranexamic acid-associated fatal status epilepticus in a paediatric non-cardiac surgery: A case report and literature review. ( Aboul-Fotouh, S; Habib, MZ; Hassan, BEE; Magdy, SM, 2022) |
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 5.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| "Concerned patients present with Leigh syndrome symptoms or a Leigh-like syndrome." | 5.72 | A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report. ( Lutz, S; Paraschaki, G; Preusse, M, 2022) |
| "Thereafter, the seizure subsided after the discontinuation of propofol infusion, and the patient was shifted to fentanyl and dexmedetomidine infusion for the maintenance of anesthesia." | 5.62 | Intraoperative refractory status epilepticus caused by propofol -a case report. ( Kumar, A; Kumar, N, 2021) |
| "Ketamine was used in 63/79 patients (80%)." | 5.56 | Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine. ( Ciccotto, G; Iwuchukwu, IO; Khan, F; Khandker, N; McGrade, H; Menon, U; Poongkunran, M; Ramsay, E; Sabharwal, V; Talahma, M, 2020) |
| "Propofol is a widely used rapidly acting sedating or hypnotic agent in the intensive care setting." | 5.35 | Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. ( Ko, DY; Rison, RA, 2009) |
| "Clonazepam (CZP) was administered with PRO, and other antiepileptic drugs (AEDs) concomitant with PRO and THP." | 5.32 | Propofol treatment of refractory status epilepticus: a study of 31 episodes. ( Bogousslavsky, J; Despland, PA; Reichhart, MD; Rossetti, AO; Schaller, MD, 2004) |
| "Status epilepticus is commonly refractory to first-line therapy, and thus better treatments are needed." | 5.31 | Propofol in subanesthetic doses terminates status epilepticus in a rodent model. ( Holtkamp, M; Tong, X; Walker, MC, 2001) |
| "Status epilepticus is one of the most frequent neurological emergencies in the intensive care unit." | 5.29 | Propofol in the management of refractory status epilepticus: a case report. ( Borgeat, A; Jallon, P; Suter, PM; Wilder-Smith, OH, 1994) |
| "This article will review the different therapeutic options for status, from early treatment at home to the different first-line (benzodiazepines), second-line (phenobarbital, valproic acid, phenytoin, levetiracetam and lacosamide) or third-line treatments, which include both pharmacological (anaesthetics, propofol, ketamine, lidocaine, topiramate, brivaracetam or perampanel) and non-pharmacological (ketogenic diet, immunomodulatory treatments or epilepsy surgery) therapies." | 5.22 | [Paediatric status epilepticus]. ( García-Peñas, JJ; González-Alguacil, E; Soto-Insuga, V, 2022) |
| "To evaluate the efficacy and safety of ketamine (KE) in the management of refractory convulsive status epilepticus (RSE) in children." | 5.16 | Efficacy and safety of ketamine in refractory status epilepticus in children. ( Cecchi, C; Guerrini, R; Ilvento, L; L'Erario, M; Mirabile, L; Pisano, T; Rosati, A, 2012) |
| "To assess safety and efficacy of propofol and thiopental for refractory status epilepticus (RSE) in children, the authors reviewed 34 episodes of RSE." | 5.11 | Propofol and thiopental for refractory status epilepticus in children. ( Blussé van Oud-Alblas, HJ; Braun, KP; Malingré, M; van Gestel, JP; van Nieuwenhuizen, O; Ververs, FF, 2005) |
| "To explore outcome differences between propofol and midazolam (MDL) therapy for refractory status epilepticus (RSE)." | 5.09 | Propofol and midazolam in the treatment of refractory status epilepticus. ( Bertram, EH; Bleck, TP; Prasad, A; Worrall, BB, 2001) |
| "We studied the safety and efficacy of intravenous propofol in the out-of-hospital treatment of convulsive status epilepticus (SE) in 8 patients (age 29-70 years), 4 of them with posttraumatic epilepsy." | 5.08 | Propofol in prehospital treatment of convulsive status epilepticus. ( Kuisma, M; Roine, RO, 1995) |
| "We compared propofol with high-dose barbiturates in the treatment of refractory status epilepticus (RSE) and propose a protocol for the administration of propofol in RSE in adults, correlating propofol's effect with plasma levels." | 5.08 | Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. ( Dulaney, E; Kramer, TH; O'Meeghan, R; Raps, EC; Skaar, DJ; Stecker, MM, 1998) |
| "Several studies have compared the efficacy and safety of propofol and barbiturates in the treatment of refractory status epilepticus (RSE)." | 5.01 | Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus. ( Lu, Y; Yu, Y; Yue, H; Zhang, Q, 2019) |
| " This study aims to report the first propofol-induced refractory status epilepticus (SE) in patients with BECTS after 16 years of age, and to review SE in BECTS or induced by propofol." | 5.01 | Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review. ( Lu, L; Xiao, Y; Xiong, W; Zhang, Y; Zhou, D, 2019) |
| "Propofol Infusion Syndrome (PRIS) is a rare but potentially lethal adverse reaction secondary to the continuous intravenous infusion of this drug." | 4.98 | [Propofol Infusion Syndrome in a refractory epileptic status case]. ( Ammann, R; Correa, A; Diettes, A; López, N; Riveros, R; Torres, F, 2018) |
| "To compare the efficacy, adverse effects, and short- and long-term outcomes of refractory status epilepticus (RSE) treated with one of the two anaesthetic agents, thiopental sodium or propofol." | 4.95 | Propofol versus thiopental sodium for the treatment of refractory status epilepticus. ( Kalaivani, M; Prabhakar, H, 2017) |
| "Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with intravenous anesthetic compounds, such as thiopental, propofol or midazolam." | 4.85 | [Drug treatment of refractory status epilepticus]. ( Rossetti, AO; Santoli, F, 2009) |
| "To discuss mainly the use of propofol and barbiturates in the anesthesia of refractory status epilepticus (RSE)." | 4.84 | Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. ( Kälviäinen, R; Parviainen, I; Ruokonen, E, 2007) |
| "While the treatment of refractory status epilepticus (SE) relies on the use of anesthetic agents, mostly barbiturates, propofol, or midazolam, the study of the available literature discloses that the evidence level is low." | 4.84 | Which anesthetic should be used in the treatment of refractory status epilepticus? ( Rossetti, AO, 2007) |
| "Several guidelines recommend the use of propofol for the treatment of refractory status epilepticus." | 4.82 | Propofol in status epilepticus: little evidence, many dangers? ( Niermeijer, JM; Uiterwaal, CS; Van Donselaar, CA, 2003) |
| "New continuous infusion antiepileptic drugs (cIV-AEDs) offer alternatives to pentobarbital for the treatment of refractory status epilepticus (RSE)." | 4.81 | Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. ( Claassen, J; Emerson, RG; Hirsch, LJ; Mayer, SA, 2002) |
| "To provide a review of the proposed mechanism of action, clinical efficacy, adverse effects, and therapeutic considerations associated with the use of propofol in the management of patients with refractory status epilepticus." | 4.80 | Role of propofol in refractory status epilepticus. ( Brown, LA; Levin, GM, 1998) |
| "To compare the effect on mortality and length of hospital stay of propofol with that of sodium thiopentone for the management of dogs with status epilepticus (SE) and refractory status epilepticus (RSE)." | 4.31 | Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs. ( Alzate, D; Araos, J; Donati, PA; Espiñeira, I; Jensen, M; Pellegrino, F; Tunesi, M, 2023) |
| "Propofol aggravated the tonic seizures." | 4.31 | Lennox-Gastaut syndrome characterized by super-refractory status epilepticus treated with high-dose anesthetics: A case report. ( Chen, W; Chong, Z; Du, J; Liang, Y; Xu, G; Yang, X; Zhao, L, 2023) |
| "LMR-101 is a bisphenol derivative of propofol, a short-acting general anesthetic, which is also used to manage status epilepticus (SE)." | 4.02 | LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors. ( An, L; Chen, T; Guo, S; Huang, X; Liu, L; Mei, Q; Sun, X; Tian, H; Wang, R; Zhao, Y, 2021) |
| "This case series highlights the potential benefits of a ketamine-dexmedetomidine infusion combined with mild hypothermia for the treatment of status epilepticus refractory to GABAergic therapy in dogs suffering from idiopathic epilepsy." | 3.96 | Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy. ( D'Urso, ES; Di Cesare, F; Gioeni, D; Rabbogliatti, V; Ravasio, G, 2020) |
| "This clinical case highlights that in comatose patients as consequence of metaldehyde poisoning, a v-EEG evaluation should be perform in order to rule out the existence of NCSE." | 3.88 | Super-refractory nonconvulsive status epilepticus due to self-poisoning with metaldehyde. ( Bosque-Varela, P; Fernández-Torre, JL; Hernández-Hernández, MA; Orizaola, P; Paramio-Paz, A; Rodríguez-Borregán, JC, 2018) |
| "The aim was to describe the safety and efficacy of (S)-ketamine [(S)-KET] in a series of patients with refractory and super-refractory status epilepticus (RSE and SRSE) in a specialized neurological intensive care unit (NICU)." | 3.83 | (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study. ( Butz, K; Dobesberger, J; Höfler, J; Kalss, G; Kuchukhidze, G; Leitinger, M; Novak, H; Pilz, G; Rohracher, A; Taylor, A; Trinka, E; Zimmermann, G, 2016) |
| "Propofol infusion syndrome (PRIS), a rare complication of propofol sedation, is associated with high mortality." | 3.81 | Therapeutic plasma exchange as treatment for propofol infusion syndrome. ( Levin, PD; Levin, V; Rund, D; Sprung, CL; Weissman, C, 2015) |
| " Propofol versus thiopental sodium for the treatment ofrefractory status epilepticus." | 3.79 | Commentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’. ( Buchhalter, J; Stang, A, 2013) |
| "A case of PRIS is described in a 17-year-old female with refractory status epilepticus (RSE) who was receiving high-dose propofol for seizure control and sedation." | 3.77 | Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation. ( Al Habash, O; Boutoille, D; Bretonniere, C; Derkinderen, P; Gabillet, L; Guitton, C; Latour, P; Rigal, JC; Villers, D, 2011) |
| "To retrospectively study effect and safety of propofol treatment in adult refractory generalised tonic clonic status epilepticus." | 3.77 | Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. ( Engelsen, BA; Flaatten, H; Gilhus, NE; Power, KN, 2011) |
| "Seizures or seizure-like phenomena which are mostly convulsive have been observed during the induction, maintenance and withdrawal phases of propofol administration." | 3.77 | Propofol withdrawal seizures: non-epileptic nature of seizures in a patient with recently controlled status epilepticus. ( Abou-Khalil, B; Arain, A; Patton, T; Smithson, K; Sonmezturk, HH; Zubair, S, 2011) |
| "Here we describe a case of propofol-related infusion syndrome (PRIS) in a child with malignant refractory status epilepticus treated with partial-exchange blood transfusion (PEBT), an innovative method of resuscitation that has the potential to reduce the mortality rate associated with this syndrome." | 3.76 | Partial-exchange blood transfusion: an effective method for preventing mortality in a child with propofol infusion syndrome. ( Asuncion, A; Coquillon, P; Da-Silva, SS; Gavrilita, C; Wong, R, 2010) |
| "To describe outcome of treatment with propofol and phenobarbital for status epilepticus (SE) after portosystemic shunt (PSS) attenuation." | 3.76 | Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbital. ( Claeys, S; Daminet, S; de Rooster, H; Gommeren, K; Hamaide, A, 2010) |
| " Two animal models of TLE--amygdala kindling and pilocarpine-induced status epilepticus (Pilo-SE)--were tested." | 3.75 | Pilocarpine model of temporal lobe epilepsy shows enhanced response to general anesthetics. ( Leung, LS; Long, JJ; Luo, T; McMurran, TJ; Shen, B; Stewart, L, 2009) |
| "Propofol is a sedative, anesthetic, and antiepileptic agent that is frequently used in patients with refractory status epilepticus." | 3.75 | Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. ( Hoel, R; Iyer, VN; Rabinstein, AA, 2009) |
| "Propofol is increasingly used for the treatment of status epilepticus due to the ease of use and tolerability, even if safety data from randomized clinical trials are lacking." | 3.74 | Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. ( Harris, BT; Jobst, BC; Zarovnaya, EL, 2007) |
| "To study prospectively the effects of propofol anesthesia on seizure control, hemodynamics and course of intensive care in patients with refractory status epilepticus." | 3.73 | Propofol in the treatment of refractory status epilepticus. ( Kälviäinen, R; Mervaala, E; Parviainen, I; Ruokonen, E; Uusaro, A, 2006) |
| "Propofol is used for the treatment of refractory status epilepticus." | 3.72 | Fatal propofol infusion syndrome in association with ketogenic diet. ( Baumeister, FA; Eberhardt, J; Holthausen, H; Kunkel, J; Liebhaber, GM; Oberhoffer, R; Peters, J, 2004) |
| "A short cut review was carried out to establish whether propofol is effective at stopping fitting in resistant status epilepticus." | 3.71 | Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Propofol for resistant status epilepticus. ( Carley, S; Crawford, I, 2002) |
| "Three weeks after diagnosis of nonconvulsive status epilepticus, general anesthesia was induced with propofol and titrated to burst suppression on the electroencephalogram (EEG)." | 3.70 | Treatment of refractory complex-partial status epilepticus with propofol: case report. ( Begemann, M; Rowan, AJ; Tuhrim, S, 2000) |
| " Her seizures promptly stopped after administration of propofol (3 mg/kg bolus followed by infusion of 100 micrograms/kg/min)." | 3.69 | Treatment of convulsive status epilepticus with propofol: case report. ( Harrison, AM; Lugo, RA; Schunk, JE, 1997) |
| "We have examined the anticonvulsant properties of propofol in high doses in two experimental models of status epilepticus: generalized pentylenetetrazol (PTZ)-induced seizures and partial, cortically applied penicillin G-induced seizures." | 3.68 | Propofol anticonvulsant activity in experimental epileptic status. ( Caria, MA; De Riu, PL; Mameli, O; Melis, F; Mulas, M; Petruzzi, V; Testa, C, 1992) |
| "Two patients with status epilepticus who were resistant to conventional treatment but responded to propofol infusions are reported." | 3.68 | Propofol infusion for control of status epilepticus. ( Grant, IS; Kapadia, F; Mackenzie, SJ, 1990) |
| "Usually, TXA-associated seizures persist for a few minutes with no progression into status epilepticus." | 2.82 | Tranexamic acid-associated fatal status epilepticus in a paediatric non-cardiac surgery: A case report and literature review. ( Aboul-Fotouh, S; Habib, MZ; Hassan, BEE; Magdy, SM, 2022) |
| "Status epilepticus is defined as epileptic seizure with the duration for over 30 min or clustered seizure without complete recovery of consciousness for 30 min or more." | 2.50 | [Treatment of status epilepticus]. ( Yamanouchi, H, 2014) |
| "Outcome prediction is more difficult in comatose survivors of cardiac arrest who are treated with hypothermia than in those who are kept normothermic." | 2.48 | Prognosis of coma after cardiac arrest in the era of hypothermia. ( De Georgia, M; Raad, B, 2012) |
| " For each class, the dosing scheme and practical issues related to administration are described, based on evidence when available in the literature." | 2.45 | [Drugs for status epilepticus treatment]. ( Mazoit, JX; Navarro, V, 2009) |
| "We reviewed the current diagnosis and treatment of status epilepticus (SE)." | 2.42 | [Current diagnosis and treatment of status epilepticus]. ( Akamatsu, N; Tsuji, S, 2003) |
| "Status epilepticus is a major medical emergency associated with significant morbidity and mortality." | 2.42 | The management of status epilepticus. ( Marik, PE; Varon, J, 2004) |
| "Status epilepticus is a serious medical emergency that requires prompt and appropriate intervention." | 2.41 | Status epilepticus. ( Fiallos, MR; Hanhan, UA; Orlowski, JP, 2001) |
| "Once SE is controlled, prevention of seizure recurrence should be individualized to each patient." | 2.40 | Management approaches to prolonged seizures and status epilepticus. ( Bleck, TP, 1999) |
| "Midazolam has become the preferred benzodiazepine in pre- and in-hospital settings, both in children and adults." | 1.91 | Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012-2021) from a University Hospital in Germany. ( Czabanka, M; Kieslich, M; Merker, M; Purwien, L; Ronellenfitsch, MW; Rosenow, F; Schubert-Bast, S; Strzelczyk, A; Willems, LM, 2023) |
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 1.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| "Concerned patients present with Leigh syndrome symptoms or a Leigh-like syndrome." | 1.72 | A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report. ( Lutz, S; Paraschaki, G; Preusse, M, 2022) |
| "Thereafter, the seizure subsided after the discontinuation of propofol infusion, and the patient was shifted to fentanyl and dexmedetomidine infusion for the maintenance of anesthesia." | 1.62 | Intraoperative refractory status epilepticus caused by propofol -a case report. ( Kumar, A; Kumar, N, 2021) |
| "The global burden of seizure disorders is apparent and necessitates the effective management of patients with status epilepticus (SE)." | 1.62 | The Role of Tourniquet Placement in Management of a Patient With Status Epilepticus. ( Amarath-Madav, R; Loeffler, P; McCollum, D, 2021) |
| "Ketamine was used in 63/79 patients (80%)." | 1.56 | Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine. ( Ciccotto, G; Iwuchukwu, IO; Khan, F; Khandker, N; McGrade, H; Menon, U; Poongkunran, M; Ramsay, E; Sabharwal, V; Talahma, M, 2020) |
| "Propofol was effective, exhibiting high efficacy and potency for terminating seizure activity quickly in pediatric and adult animals, suggesting it may be an effective anticonvulsant for NA-induced seizures in pediatric populations." | 1.56 | Evaluation of fosphenytoin, levetiracetam, and propofol as treatments for nerve agent-induced seizures in pediatric and adult rats. ( Ardinger, CE; Berger, KE; Dunn, EN; Haines, KM; Jackson Piercy, CE; Lee-Stubbs, RB; Matson, LM; McCarren, HS; McDonough, JH; Miller-Smith, SM; Whitten, KA, 2020) |
| "At discharge, all survivors were seizure free." | 1.51 | Treatment options in pediatric super-refractory status epilepticus. ( Arayakarnkul, P; Chomtho, K, 2019) |
| "Ketamine was used in most severe cases." | 1.42 | Preliminary results of the global audit of treatment of refractory status epilepticus. ( Ferlisi, M; Grade, M; Hocker, S; Shorvon, S; Trinka, E, 2015) |
| "The pattern was associated with myoclonus in 11 patients." | 1.42 | Low frequency nonevolving generalized periodic epileptiform discharges and the borderland of hypoxic nonconvulsive status epilepticus in comatose patients after cardiac arrest. ( Koutroumanidis, M; Sakellariou, D, 2015) |
| "Phenytoin was the most prescribed second-line treatment (41%) but statistically significantly least effective (22% versus 86% seizure cessation, p<0." | 1.40 | A retrospective observational study of current treatment for generalized convulsive status epilepticus. ( Fountain, NB; Langer, JE, 2014) |
| "Pentobarbital was chosen later in the therapy for all ages." | 1.39 | Treatment of status epilepticus: an international survey of experts. ( Alldredge, B; Bell, R; Bleck, TP; Brophy, GM; Claassen, J; Glauser, T; LaRoche, SM; Riviello, JJ; Shutter, L; Sperling, MR; Treiman, DM; Vespa, PM, 2013) |
| " However, the present case suggests using the lowest possible dosage in MDR1-deficient dogs and pet owners should be advised of potential complications." | 1.38 | [Milbemycinoxime intoxication in a Miniature Australian Shepherd dog]. ( Baumstark, M; Burkhardt, W; Kook, P; Matos, J; Reusch, C, 2012) |
| "Thiopental was added for treatment of intracranial hypertension." | 1.38 | Frequency of non-convulsive seizures and non-convulsive status epilepticus in subarachnoid hemorrhage patients in need of controlled ventilation and sedation. ( Lindgren, C; Naredi, S; Nordh, E; Olivecrona, M, 2012) |
| "Status epilepticus is a common neurological emergency in childhood and associated with significant morbidity and mortality." | 1.37 | Status epilepticus. ( Gulati, S; Lodha, R; Raj, D, 2011) |
| "Propofol is a widely used rapidly acting sedating or hypnotic agent in the intensive care setting." | 1.35 | Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. ( Ko, DY; Rison, RA, 2009) |
| "Clonazepam (CZP) was administered with PRO, and other antiepileptic drugs (AEDs) concomitant with PRO and THP." | 1.32 | Propofol treatment of refractory status epilepticus: a study of 31 episodes. ( Bogousslavsky, J; Despland, PA; Reichhart, MD; Rossetti, AO; Schaller, MD, 2004) |
| "The use of pharmacologic coma (PC) to treat status epilepticus (SE) is not always successful, and there are no guidelines for the duration of PC in an attempt to achieve seizure control." | 1.32 | Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. ( Bramstedt, KA; Morris, HH; Tanner, A, 2004) |
| "Status epilepticus is commonly refractory to first-line therapy, and thus better treatments are needed." | 1.31 | Propofol in subanesthetic doses terminates status epilepticus in a rodent model. ( Holtkamp, M; Tong, X; Walker, MC, 2001) |
| "Status epilepticus is one of the most frequent neurological emergencies in the intensive care unit." | 1.29 | Propofol in the management of refractory status epilepticus: a case report. ( Borgeat, A; Jallon, P; Suter, PM; Wilder-Smith, OH, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.54) | 18.7374 |
| 1990's | 24 (18.46) | 18.2507 |
| 2000's | 42 (32.31) | 29.6817 |
| 2010's | 44 (33.85) | 24.3611 |
| 2020's | 18 (13.85) | 2.80 |
| Authors | Studies |
|---|---|
| Howing, CE | 1 |
| Razi, F | 1 |
| Hakmeh, W | 1 |
| Preusse, M | 1 |
| Paraschaki, G | 1 |
| Lutz, S | 1 |
| Aboul-Fotouh, S | 1 |
| Habib, MZ | 1 |
| Magdy, SM | 1 |
| Hassan, BEE | 1 |
| Chiu, WT | 1 |
| Campozano, V | 1 |
| Schiefecker, A | 1 |
| Rodriguez, DR | 1 |
| Ferreira, D | 1 |
| Headlee, A | 1 |
| Zeidan, S | 1 |
| Grinea, A | 1 |
| Huang, YH | 1 |
| Doyle, K | 1 |
| Shen, Q | 1 |
| Gómez, D | 1 |
| Hocker, SE | 1 |
| Rohaut, B | 1 |
| Sonneville, R | 1 |
| Hong, CT | 1 |
| Demeret, S | 1 |
| Kurtz, P | 1 |
| Maldonado, N | 1 |
| Helbok, R | 1 |
| Fernandez, T | 1 |
| Claassen, J | 4 |
| Patel, S | 1 |
| Soto-Insuga, V | 1 |
| González-Alguacil, E | 1 |
| García-Peñas, JJ | 1 |
| Espiñeira, I | 1 |
| Alzate, D | 1 |
| Araos, J | 1 |
| Pellegrino, F | 1 |
| Tunesi, M | 1 |
| Jensen, M | 1 |
| Donati, PA | 1 |
| Yang, X | 1 |
| Xu, G | 1 |
| Chong, Z | 1 |
| Liang, Y | 1 |
| Du, J | 1 |
| Zhao, L | 1 |
| Chen, W | 1 |
| Purwien, L | 1 |
| Schubert-Bast, S | 1 |
| Kieslich, M | 1 |
| Ronellenfitsch, MW | 1 |
| Merker, M | 1 |
| Czabanka, M | 1 |
| Willems, LM | 1 |
| Rosenow, F | 2 |
| Strzelczyk, A | 1 |
| Sabharwal, V | 2 |
| Poongkunran, M | 1 |
| Talahma, M | 1 |
| Iwuchukwu, IO | 1 |
| Ramsay, E | 2 |
| Khan, F | 2 |
| Menon, U | 1 |
| Ciccotto, G | 1 |
| Khandker, N | 1 |
| McGrade, H | 2 |
| Liu, X | 1 |
| Geng, J | 1 |
| Guo, H | 1 |
| Zhao, H | 1 |
| Ai, Y | 1 |
| Dunn, EN | 1 |
| Matson, LM | 1 |
| Haines, KM | 1 |
| Whitten, KA | 1 |
| Lee-Stubbs, RB | 1 |
| Berger, KE | 1 |
| McCarren, HS | 1 |
| Ardinger, CE | 1 |
| Jackson Piercy, CE | 1 |
| Miller-Smith, SM | 1 |
| McDonough, JH | 1 |
| Gioeni, D | 1 |
| Di Cesare, F | 1 |
| D'Urso, ES | 1 |
| Rabbogliatti, V | 1 |
| Ravasio, G | 1 |
| Kumar, A | 3 |
| Kumar, N | 1 |
| Caronna, E | 1 |
| Vilaseca, A | 1 |
| Maria Gràcia Gozalo, R | 1 |
| Sanchez Corral, A | 1 |
| Santafé, M | 1 |
| Sueiras, M | 1 |
| Guzmán, L | 1 |
| Quintana, M | 1 |
| Toledo-Argany, M | 1 |
| Santamarina, E | 1 |
| Amarath-Madav, R | 1 |
| Loeffler, P | 1 |
| McCollum, D | 1 |
| Zhao, Y | 1 |
| An, L | 1 |
| Guo, S | 1 |
| Huang, X | 1 |
| Tian, H | 1 |
| Liu, L | 1 |
| Chen, T | 1 |
| Sun, X | 1 |
| Mei, Q | 1 |
| Wang, R | 1 |
| Shamloul, R | 1 |
| El-Tamawy, M | 1 |
| Amer, H | 1 |
| Kishk, N | 1 |
| Shaker, E | 1 |
| Nawito, A | 1 |
| Basheer, M | 1 |
| Alieldin, N | 1 |
| Othman, A | 1 |
| Talaat, L | 1 |
| Fernández-Torre, JL | 3 |
| Paramio-Paz, A | 1 |
| Rodríguez-Borregán, JC | 1 |
| Orizaola, P | 1 |
| Bosque-Varela, P | 1 |
| Hernández-Hernández, MA | 2 |
| Chen, J | 1 |
| Xie, L | 1 |
| Hu, Y | 1 |
| Lan, X | 1 |
| Jiang, L | 1 |
| López, N | 1 |
| Correa, A | 1 |
| Ammann, R | 1 |
| Diettes, A | 1 |
| Riveros, R | 1 |
| Torres, F | 1 |
| Arayakarnkul, P | 1 |
| Chomtho, K | 1 |
| Zhang, Q | 1 |
| Yu, Y | 1 |
| Lu, Y | 1 |
| Yue, H | 1 |
| Muhlhofer, WG | 1 |
| Layfield, S | 1 |
| Lowenstein, D | 1 |
| Lin, CP | 1 |
| Johnson, RD | 1 |
| Saini, S | 1 |
| Szaflarski, JP | 1 |
| Lu, L | 1 |
| Xiong, W | 1 |
| Zhang, Y | 1 |
| Xiao, Y | 1 |
| Zhou, D | 1 |
| Prabhakar, H | 4 |
| Bindra, A | 2 |
| Singh, GP | 2 |
| Kalaivani, M | 4 |
| Buchhalter, J | 1 |
| Stang, A | 1 |
| Yamanouchi, H | 1 |
| Langer, JE | 1 |
| Fountain, NB | 1 |
| Dulin, JD | 1 |
| Noreika, DM | 1 |
| Coyne, PJ | 1 |
| Chen, L | 1 |
| Lim, FA | 1 |
| Koutroumanidis, M | 2 |
| Sakellariou, D | 2 |
| Tsirka, V | 1 |
| Levin, PD | 1 |
| Levin, V | 1 |
| Weissman, C | 1 |
| Sprung, CL | 1 |
| Rund, D | 1 |
| Arbour, RB | 1 |
| Dissin, J | 1 |
| Ferlisi, M | 1 |
| Hocker, S | 1 |
| Grade, M | 1 |
| Trinka, E | 2 |
| Shorvon, S | 1 |
| Fang, YT | 1 |
| Wu, VC | 1 |
| Tang, SC | 1 |
| Yeh, HM | 1 |
| Martinez, R | 1 |
| Shumate, R | 1 |
| Dave, H | 1 |
| Iwuchukwu, I | 1 |
| Karlov, VA | 1 |
| Vlasov, PN | 1 |
| Gladov, BP | 1 |
| Kamelkova, EG | 1 |
| Sonis, J | 1 |
| Borczuk, P | 1 |
| Ptak, T | 1 |
| Miller, ES | 1 |
| Höfler, J | 1 |
| Rohracher, A | 1 |
| Kalss, G | 1 |
| Zimmermann, G | 1 |
| Dobesberger, J | 1 |
| Pilz, G | 1 |
| Leitinger, M | 1 |
| Kuchukhidze, G | 1 |
| Butz, K | 1 |
| Taylor, A | 1 |
| Novak, H | 1 |
| Legriel, S | 1 |
| Oddo, M | 2 |
| Brophy, GM | 2 |
| Flügel, D | 1 |
| Arif, H | 1 |
| Hirsch, LJ | 2 |
| Adams, BD | 1 |
| Barry, DJ | 1 |
| Navarro, V | 1 |
| Mazoit, JX | 1 |
| Rossetti, AO | 5 |
| Liaudet, L | 1 |
| Kaplan, PW | 1 |
| Santoli, F | 1 |
| Rison, RA | 1 |
| Ko, DY | 1 |
| Long, JJ | 1 |
| Shen, B | 1 |
| Luo, T | 1 |
| Stewart, L | 1 |
| McMurran, TJ | 1 |
| Leung, LS | 1 |
| Iyer, VN | 1 |
| Hoel, R | 1 |
| Rabinstein, AA | 1 |
| Musialowicz, T | 1 |
| Mervaala, E | 2 |
| Kälviäinen, R | 3 |
| Uusaro, A | 2 |
| Ruokonen, E | 3 |
| Parviainen, I | 3 |
| Da-Silva, SS | 1 |
| Wong, R | 1 |
| Coquillon, P | 1 |
| Gavrilita, C | 1 |
| Asuncion, A | 1 |
| Guitton, C | 1 |
| Gabillet, L | 1 |
| Latour, P | 1 |
| Rigal, JC | 1 |
| Boutoille, D | 1 |
| Al Habash, O | 1 |
| Derkinderen, P | 1 |
| Bretonniere, C | 1 |
| Villers, D | 1 |
| Gommeren, K | 1 |
| Claeys, S | 1 |
| de Rooster, H | 1 |
| Hamaide, A | 1 |
| Daminet, S | 1 |
| Milligan, TA | 1 |
| Vulliémoz, S | 1 |
| Michaelides, C | 1 |
| Bertschi, M | 1 |
| Lee, JW | 1 |
| Ku, BD | 1 |
| Park, KC | 1 |
| Yoon, SS | 1 |
| Raj, D | 1 |
| Gulati, S | 1 |
| Lodha, R | 1 |
| Power, KN | 1 |
| Flaatten, H | 1 |
| Gilhus, NE | 1 |
| Engelsen, BA | 1 |
| Zubair, S | 1 |
| Patton, T | 1 |
| Smithson, K | 1 |
| Sonmezturk, HH | 1 |
| Arain, A | 1 |
| Abou-Khalil, B | 1 |
| Fernandez, A | 1 |
| De Georgia, M | 1 |
| Raad, B | 1 |
| Burkhardt, W | 1 |
| Baumstark, M | 1 |
| Matos, J | 1 |
| Reusch, C | 1 |
| Kook, P | 1 |
| Lindgren, C | 1 |
| Nordh, E | 1 |
| Naredi, S | 1 |
| Olivecrona, M | 1 |
| Riviello, JJ | 3 |
| LaRoche, SM | 1 |
| Sperling, MR | 1 |
| Alldredge, B | 1 |
| Bleck, TP | 5 |
| Glauser, T | 1 |
| Shutter, L | 1 |
| Treiman, DM | 1 |
| Vespa, PM | 1 |
| Bell, R | 1 |
| Rosati, A | 1 |
| L'Erario, M | 1 |
| Ilvento, L | 1 |
| Cecchi, C | 1 |
| Pisano, T | 1 |
| Mirabile, L | 1 |
| Guerrini, R | 1 |
| Arzimanoglou, A | 1 |
| Baulac, M | 1 |
| Sykes, N | 1 |
| Thorns, A | 1 |
| Niermeijer, JM | 1 |
| Uiterwaal, CS | 1 |
| Van Donselaar, CA | 1 |
| Hirsch, NP | 2 |
| Smith, M | 1 |
| Golf, M | 1 |
| Paice, JA | 1 |
| Feulner, E | 1 |
| O'Leary, C | 1 |
| Marcotte, S | 1 |
| Mulcahy, M | 1 |
| Terao, H | 1 |
| Akamatsu, N | 1 |
| Tsuji, S | 1 |
| Reichhart, MD | 1 |
| Schaller, MD | 1 |
| Despland, PA | 1 |
| Bogousslavsky, J | 1 |
| Marik, PE | 1 |
| Varon, J | 1 |
| Baumeister, FA | 1 |
| Oberhoffer, R | 1 |
| Liebhaber, GM | 1 |
| Kunkel, J | 1 |
| Eberhardt, J | 1 |
| Holthausen, H | 1 |
| Peters, J | 1 |
| Bramstedt, KA | 1 |
| Morris, HH | 1 |
| Tanner, A | 1 |
| Martella, G | 1 |
| De Persis, C | 1 |
| Bonsi, P | 1 |
| Natoli, S | 1 |
| Cuomo, D | 1 |
| Bernardi, G | 1 |
| Calabresi, P | 1 |
| Pisani, A | 1 |
| Augoustides, JG | 1 |
| Culp, KE | 1 |
| Ochroch, AE | 1 |
| Milas, BL | 1 |
| Schor, NF | 1 |
| van Gestel, JP | 1 |
| Blussé van Oud-Alblas, HJ | 1 |
| Malingré, M | 1 |
| Ververs, FF | 1 |
| Braun, KP | 1 |
| van Nieuwenhuizen, O | 1 |
| Malmgren, K | 1 |
| Ide, A | 1 |
| Minicucci, F | 1 |
| Muscas, G | 1 |
| Perucca, E | 1 |
| Capovilla, G | 1 |
| Vigevano, F | 1 |
| Tinuper, P | 1 |
| Zarovnaya, EL | 1 |
| Jobst, BC | 1 |
| Harris, BT | 1 |
| Ahlen, K | 1 |
| Buckley, C | 1 |
| Pulsford, AH | 1 |
| Bhatia, R | 1 |
| Vibha, D | 1 |
| Srivastava, MV | 1 |
| Prasad, K | 1 |
| Tripathi, M | 1 |
| Bhushan Singh, M | 1 |
| Kuisma, M | 1 |
| Roine, RO | 1 |
| Merigian, KS | 1 |
| Browning, RG | 1 |
| Leeper, KV | 1 |
| Hantson, P | 1 |
| Van Brandt, N | 1 |
| Verbeeck, R | 1 |
| Guérit, JM | 1 |
| Mahieu, P | 1 |
| Borgeat, A | 1 |
| Wilder-Smith, OH | 1 |
| Jallon, P | 1 |
| Suter, PM | 1 |
| Gemma, M | 1 |
| Cipriani, A | 1 |
| Mungo, M | 1 |
| Mazzarino, A | 2 |
| De Maria, G | 2 |
| Candiani, A | 2 |
| Pitt-Miller, PL | 1 |
| Elcock, BJ | 1 |
| Maharaj, M | 1 |
| Cascino, GD | 1 |
| Huff, JS | 1 |
| Walker, MC | 2 |
| Howard, RS | 1 |
| Smith, SJ | 1 |
| Miller, DH | 1 |
| Shorvon, SD | 1 |
| Harrison, AM | 1 |
| Lugo, RA | 1 |
| Schunk, JE | 1 |
| Hanna, JP | 1 |
| Ramundo, ML | 1 |
| Stecker, MM | 1 |
| Kramer, TH | 1 |
| Raps, EC | 1 |
| O'Meeghan, R | 1 |
| Dulaney, E | 1 |
| Skaar, DJ | 1 |
| Tobias, JD | 1 |
| Crouteau, D | 1 |
| Shevell, M | 1 |
| Rosenblatt, B | 1 |
| Dilenge, ME | 1 |
| Andermann, F | 1 |
| Lappin, R | 1 |
| Brown, LA | 1 |
| Levin, GM | 1 |
| Begemann, M | 1 |
| Rowan, AJ | 1 |
| Tuhrim, S | 1 |
| González, C | 1 |
| Sánchez, JM | 1 |
| Holtkamp, M | 1 |
| Tong, X | 1 |
| Hanhan, UA | 1 |
| Fiallos, MR | 1 |
| Orlowski, JP | 1 |
| Prasad, A | 1 |
| Worrall, BB | 1 |
| Bertram, EH | 1 |
| Sahin, M | 1 |
| Menache, CC | 1 |
| Holmes, GL | 1 |
| Emerson, RG | 1 |
| Mayer, SA | 1 |
| Carley, S | 1 |
| Crawford, I | 1 |
| Wijdicks, EF | 1 |
| Mäkelä, JP | 1 |
| Iivanainen, M | 1 |
| Lahdensuu, M | 1 |
| De Riu, PL | 1 |
| Petruzzi, V | 1 |
| Testa, C | 1 |
| Mulas, M | 1 |
| Melis, F | 1 |
| Caria, MA | 1 |
| Mameli, O | 1 |
| Melloni, C | 1 |
| Fusari, M | 1 |
| Scesi, M | 1 |
| Franzoni, E | 1 |
| Marchiani, V | 1 |
| Martini, E | 1 |
| Querci, A | 1 |
| Camurri, F | 1 |
| Campostrini, R | 1 |
| Chilvers, CR | 1 |
| Laurie, PS | 1 |
| Mackenzie, SJ | 1 |
| Kapadia, F | 1 |
| Grant, IS | 1 |
| Wood, PR | 1 |
| Browne, GP | 1 |
| Pugh, S | 1 |
| Yanny, HF | 1 |
| Christmas, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Narcotrend Depth of Anaesthesia Monitor as an Indicator of Seizures and Burst Suppression in the Intensive Care Unit[NCT06067750] | 106 participants (Anticipated) | Observational | 2023-06-27 | Recruiting | |||
| A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus[NCT00265616] | Phase 3 | 23 participants (Actual) | Interventional | 2006-05-31 | Terminated (stopped due to Insufficient recruitment) | ||
| Efficacy of Combined Ketamine and Midazolam for Treatment of Generalized Convulsive Status Epilepticus in Children .[NCT05779657] | Phase 2/Phase 3 | 144 participants (Anticipated) | Interventional | 2023-03-21 | Recruiting | ||
| Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19)[NCT04358835] | 0 participants (Actual) | Interventional | 2020-09-01 | Withdrawn (stopped due to Study did not begin enrollment, multiple competing studies at same institution) | |||
| A Pilot Study to Assess the Efficacy of Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy[NCT05019885] | Phase 2 | 6 participants (Anticipated) | Interventional | 2022-08-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Return to baseline clinical conditions (i.e.: no new handicap, no death) (NCT00265616)
Timeframe: 21 days
| Intervention | participants (Number) |
|---|---|
| Propofol | 5 |
| Thiopental/Pentobarbital | 3 |
(NCT00265616)
Timeframe: Up to 3 months
| Intervention | days (Median) |
|---|---|
| Propofol | 4 |
| Thiopental/Pentobarbital | 13.5 |
(NCT00265616)
Timeframe: 10 days
| Intervention | participants (Number) |
|---|---|
| Propofol | 7 |
| Thiopental/Pentobarbital | 5 |
(NCT00265616)
Timeframe: 10 days
| Intervention | participants (Number) |
|---|---|
| Propofol | 7 |
| Thiopental/Pentobarbital | 6 |
Propofol infusion syndrome (PRIS) is a severe metabolic alteration with elevation of lactate, CK, and triglycerides. (NCT00265616)
Timeframe: 10 days
| Intervention | participants (Number) |
|---|---|
| Propofol | 1 |
| Thiopental/Pentobarbital | 0 |
Control of status epilepticus refractory to benzodiazepines and a first antiepileptic drug after administration of the study drug; dichotomous assessment (yes/no) (NCT00265616)
Timeframe: after return of continuous EEG activity (typically after 36 hours - 5 days)
| Intervention | participants (Number) |
|---|---|
| Propofol | 6 |
| Thiopental/Pentobarbital | 2 |
30 reviews available for propofol and Absence Status
| Article | Year |
|---|---|
Tranexamic acid-associated fatal status epilepticus in a paediatric non-cardiac surgery: A case report and literature review.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Child; Child, Preschool; Humans; Male; Propofol; Seiz | 2022 |
[Paediatric status epilepticus].
Topics: Adult; Anesthetics; Anticonvulsants; Benzodiazepines; Child; Epilepsy; Humans; Ketamine; Lacosamide; | 2022 |
[Propofol Infusion Syndrome in a refractory epileptic status case].
Topics: Anticonvulsants; Child; Female; Humans; Injections, Intravenous; Propofol; Propofol Infusion Syndrom | 2018 |
Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus.
Topics: Anticonvulsants; Barbiturates; China; Humans; Male; Odds Ratio; Propofol; Status Epilepticus | 2019 |
Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review.
Topics: Adolescent; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Hypnotics and Sedatives; Mag | 2019 |
Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Review).
Topics: Anesthetics, Intravenous; Child; Child, Preschool; Female; Humans; Male; Propofol; Randomized Contro | 2013 |
[Treatment of status epilepticus].
Topics: Anesthesia, General; Diazepam; Drug Administration Routes; Evidence-Based Medicine; Humans; Hypother | 2014 |
Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Drug Resistant Epilepsy; Humans; Propofol; Respira | 2015 |
What's new in refractory status epilepticus?
Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Barbiturates; Drug Resistance; Drug Therapy, Co | 2017 |
Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Drug Resistant Epilepsy; Humans; Propofol; Respira | 2017 |
Topics: Adult; Anticonvulsants; Benzodiazepines; Drug Resistant Epilepsy; Electroencephalography; Humans; Mi | 2017 |
Treatment of status epilepticus.
Topics: Aged; Anticonvulsants; Barbiturates; Benzodiazepines; Electroencephalography; Emergency Medical Serv | 2008 |
[Drugs for status epilepticus treatment].
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Fructose; Humans; Hypnotics and Sedatives; Levetirac | 2009 |
[Drug treatment of refractory status epilepticus].
Topics: Anticonvulsants; Barbiturates; Drug Resistance; Humans; Hypnotics and Sedatives; Midazolam; Propofol | 2009 |
Refractory status epilepticus.
Topics: Anticonvulsants; Barbiturates; Critical Care; Diet, Ketogenic; Female; Humans; Hypothermia, Induced; | 2012 |
Prognosis of coma after cardiac arrest in the era of hypothermia.
Topics: Animals; Biomarkers; Brain Damage, Chronic; Clinical Trials as Topic; Coma; Combined Modality Therap | 2012 |
Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Humans; Propofol; Status Epilepticus; Thiopental | 2012 |
Recent developments in treatment of status epilepticus: a review.
Topics: Anticonvulsants; Humans; Injections; Midazolam; Propofol; Status Epilepticus; Valproic Acid | 2002 |
Propofol in status epilepticus: little evidence, many dangers?
Topics: Anticonvulsants; Clinical Trials as Topic; Humans; Mortality; Practice Guidelines as Topic; Propofol | 2003 |
[Current diagnosis and treatment of status epilepticus].
Topics: Anesthesia, General; Animals; Anticonvulsants; Critical Care; Diagnosis, Differential; Electric Stim | 2003 |
The management of status epilepticus.
Topics: Anticonvulsants; Humans; Lorazepam; Midazolam; Propofol; Status Epilepticus | 2004 |
Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons.
Topics: Anesthetics, Intravenous; Anticonvulsants; Barbiturates; Dose-Response Relationship, Drug; Humans; M | 2007 |
Which anesthetic should be used in the treatment of refractory status epilepticus?
Topics: Anesthetics; Anesthetics, Intravenous; Anticonvulsants; Barbiturates; Coma; Electroencephalography; | 2007 |
Intensive care unit management of patients with status epilepticus.
Topics: Anesthesia, General; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule | 2007 |
Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)
Topics: Adult; Amoxapine; Drug Overdose; Female; Humans; Infusions, Intravenous; Propofol; Status Epilepticu | 1995 |
Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children.
Topics: Adolescent; Child; Critical Care; Humans; Hypnotics and Sedatives; Hypoxia; Male; Propofol; Respirat | 1998 |
Role of propofol in refractory status epilepticus.
Topics: Anticonvulsants; Humans; Propofol; Status Epilepticus; Treatment Outcome | 1998 |
Management approaches to prolonged seizures and status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; | 1999 |
Status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Midazola | 2001 |
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
Topics: Anticonvulsants; GABA Modulators; Humans; Midazolam; Pentobarbital; Propofol; Status Epilepticus | 2002 |
6 trials available for propofol and Absence Status
| Article | Year |
|---|---|
A randomized trial for the treatment of refractory status epilepticus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Barbiturates; Coma; Critical Care; Female; Humans; Hypno | 2011 |
Efficacy and safety of ketamine in refractory status epilepticus in children.
Topics: Anesthetics; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Ketamine; Male; Midaz | 2012 |
Propofol and thiopental for refractory status epilepticus in children.
Topics: Anticonvulsants; Child; Clinical Protocols; Dose-Response Relationship, Drug; Drug Administration Sc | 2005 |
Propofol in prehospital treatment of convulsive status epilepticus.
Topics: Adult; Aged; Blood Pressure; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outpatients; Prop | 1995 |
Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.
Topics: Adult; Aged; Barbiturates; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combinati | 1998 |
Propofol and midazolam in the treatment of refractory status epilepticus.
Topics: Adolescent; Adult; Aged; Anticonvulsants; APACHE; Comorbidity; Electroencephalography; Female; Human | 2001 |
94 other studies available for propofol and Absence Status
| Article | Year |
|---|---|
Resolution of status epilepticus after ketamine administration.
Topics: Aftercare; Anticonvulsants; COVID-19; Female; Humans; Infant; Ketamine; Levetiracetam; Lorazepam; Pa | 2022 |
A Case of ECHS1 Deficiency with Severe Encephalopathy and Status Epilepticus after a Propofol Sedation: Case Report.
Topics: Atrophy; Cardiomyopathies; Enoyl-CoA Hydratase; Humans; Infant; Leigh Disease; Lipid Metabolism, Inb | 2022 |
Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
Topics: Anticonvulsants; Cohort Studies; Humans; Intensive Care Units; Midazolam; Propofol; Retrospective St | 2022 |
Tranexamic acid-associated seizures in a paediatric patient.
Topics: Anticonvulsants; Child; Humans; Propofol; Seizures; Status Epilepticus; Tranexamic Acid | 2022 |
Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs.
Topics: Anesthetics; Animals; Cohort Studies; Dog Diseases; Dogs; Propofol; Retrospective Studies; Sodium; S | 2023 |
Lennox-Gastaut syndrome characterized by super-refractory status epilepticus treated with high-dose anesthetics: A case report.
Topics: Adult; Anesthetics; Anticonvulsants; Child, Preschool; Epilepsy; Humans; Lennox Gastaut Syndrome; Na | 2023 |
Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012-2021) from a University Hospital in Germany.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Child; Female; Hospitals, Universi | 2023 |
Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine.
Topics: Adult; Anesthetics, Dissociative; Anesthetics, Intravenous; Animals; Disease Management; Female; Hum | 2020 |
Propofol inhibited apoptosis of hippocampal neurons in status epilepticus through miR-15a-5p/NR2B/ERK1/2 pathway.
Topics: Anesthetics, Intravenous; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Down-Regulati | 2020 |
Evaluation of fosphenytoin, levetiracetam, and propofol as treatments for nerve agent-induced seizures in pediatric and adult rats.
Topics: Age Factors; Animals; Anticonvulsants; Brain; Disease Models, Animal; Female; Levetiracetam; Male; O | 2020 |
Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy.
Topics: Analgesics; Anesthesia, General; Animals; Body Temperature; Dexmedetomidine; Dog Diseases; Dogs; Epi | 2020 |
Intraoperative refractory status epilepticus caused by propofol -a case report.
Topics: Adult; Anticonvulsants; Humans; Male; Propofol; Seizures; Status Epilepticus; Thiopental | 2021 |
Long-term prognosis related to deep sedation in refractory status Epilepticus.
Topics: Adolescent; Adult; Aged; Barbiturates; Coma; Deep Sedation; Female; Humans; Hypnotics and Sedatives; | 2020 |
The Role of Tourniquet Placement in Management of a Patient With Status Epilepticus.
Topics: Aged; Female; Fentanyl; Humans; Propofol; Seizures; Status Epilepticus; Tourniquets | 2021 |
LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors.
Topics: Animals; Anticonvulsants; Behavior, Animal; Bicuculline; Electroencephalography; GABA-A Receptor Ant | 2021 |
Factors associated with the use of anesthetic drug infusion in patients with status epilepticus and their relation to outcome: a prospective study.
Topics: Anesthetics; Humans; Prognosis; Propofol; Prospective Studies; Retrospective Studies; Severity of Il | 2022 |
Super-refractory nonconvulsive status epilepticus due to self-poisoning with metaldehyde.
Topics: Acetaldehyde; Aged; Anticonvulsants; Coma; Female; Humans; Molluscacides; Propofol; Status Epileptic | 2018 |
Nonconvulsive status epilepticus after cessation of convulsive status epilepticus in pediatric intensive care unit patients.
Topics: Administration, Intravenous; Adolescent; Cerebral Cortex; Child; Child, Preschool; Electroencephalog | 2018 |
Treatment options in pediatric super-refractory status epilepticus.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Diet, Ketogenic; Drug Resistant Epilepsy; Ence | 2019 |
Duration of therapeutic coma and outcome of refractory status epilepticus.
Topics: Adult; Aged; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Causality; Conf | 2019 |
Commentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’.
Topics: Anesthetics, Intravenous; Female; Humans; Male; Propofol; Status Epilepticus; Thiopental | 2013 |
A retrospective observational study of current treatment for generalized convulsive status epilepticus.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Benzodiazepines; Child; Child, Preschool; Dru | 2014 |
Management of refractory status epilepticus in an actively dying patient.
Topics: Aged; Anesthetics, Intravenous; Female; Humans; Hypoxia, Brain; Male; Middle Aged; Out-of-Hospital C | 2014 |
Propofol infusion syndrome: a rare but lethal complication.
Topics: Anesthetics, Intravenous; Critical Care Nursing; Fatal Outcome; Humans; Infusions, Intravenous; Male | 2014 |
"Paradoxical" EEG response to propofol may differentiate post-cardiac arrest non-convulsive status epilepticus from diffuse irreversible cerebral anoxia.
Topics: Diagnosis, Differential; Electroencephalography; Heart Arrest; Humans; Hypnotics and Sedatives; Hypo | 2014 |
Therapeutic plasma exchange as treatment for propofol infusion syndrome.
Topics: Accidents, Traffic; Acidosis, Lactic; Acute Kidney Injury; Adolescent; Anticonvulsants; Biomarkers; | 2015 |
Predictive value of the bispectral index for burst suppression on diagnostic electroencephalogram during drug-induced coma.
Topics: Adult; Alcohol Withdrawal Seizures; Cerebral Cortex; Cohort Studies; Consciousness Monitors; Deep Se | 2015 |
Preliminary results of the global audit of treatment of refractory status epilepticus.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia, General; Anesthetics, Dissociat | 2015 |
Low frequency nonevolving generalized periodic epileptiform discharges and the borderland of hypoxic nonconvulsive status epilepticus in comatose patients after cardiac arrest.
Topics: Adult; Aged; Anticonvulsants; Benzodiazepines; Coma; Electroencephalography; Epilepsy; Female; Heart | 2015 |
Extracorporeal membrane oxygenation and sustained low-efficiency diafiltration successfully resuscitated propofol infusion syndrome during refractory status epilepticus.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Extracorporeal Membrane Oxygenation; Humans | 2015 |
Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Dissociative; Anesthetics, Intravenous; Chi | 2015 |
[Cases of non-standard approach to treatment of super-refractory status epilepticus].
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Clinical Protocols; Drug Therapy, Combination; Ele | 2015 |
Seizure and Fever.
Topics: Acyclovir; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antiviral Agents; Brain Neoplasms; Ceftri | 2016 |
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
Topics: Aged; Anesthetics; Anticonvulsants; Drug Resistant Epilepsy; Electroencephalography; Excitatory Amin | 2016 |
Tiagabine: let seizing dogs lie?
Topics: Drug Overdose; Follow-Up Studies; Humans; Hypnotics and Sedatives; Nipecotic Acids; Propofol; Risk A | 2008 |
Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia.
Topics: Aged; Anticonvulsants; Benzodiazepines; Brain Stem; Cerebral Cortex; Cohort Studies; Consciousness; | 2009 |
Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus.
Topics: Adolescent; Anticonvulsants; Fatty Liver; Female; Humans; Midazolam; Propofol; Status Epilepticus; T | 2009 |
Pilocarpine model of temporal lobe epilepsy shows enhanced response to general anesthetics.
Topics: Anesthetics, General; Animals; Brain; Consciousness Disorders; Convulsants; Disease Models, Animal; | 2009 |
Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Critical Illness; Female; Human | 2009 |
Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?
Topics: Adult; Aged; Anesthetics, Intravenous; Drug Evaluation; Electroencephalography; Female; Humans; Inte | 2010 |
Partial-exchange blood transfusion: an effective method for preventing mortality in a child with propofol infusion syndrome.
Topics: Child, Preschool; Electroencephalography; Exchange Transfusion, Whole Blood; Humans; Hypnotics and S | 2010 |
Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation.
Topics: Adolescent; Extracorporeal Membrane Oxygenation; Female; Humans; Hypnotics and Sedatives; Infusions, | 2011 |
Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbital.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Female; Liver Diseases; Male; Phenobarbital; Portal Sy | 2010 |
Dark green discoloration of the urine after prolonged propofol infusion: a case report.
Topics: Adult; Anesthetics, Intravenous; Color; Dose-Response Relationship, Drug; Humans; Infusions, Intrave | 2011 |
Status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Child; Clinical Protocols; Fructose; GABA Modulators; Humans; Keta | 2011 |
Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Internat | 2011 |
Propofol withdrawal seizures: non-epileptic nature of seizures in a patient with recently controlled status epilepticus.
Topics: Adult; Electroencephalography; Female; Humans; Propofol; Seizures; Status Epilepticus; Substance Wit | 2011 |
Utility of bilateral Bispectral index (BIS) monitoring in a comatose patient with focal nonconvulsive status epilepticus.
Topics: Aged; Aneurysm, Ruptured; Coma; Consciousness Monitors; Deep Sedation; Electroencephalography; Femal | 2012 |
[Milbemycinoxime intoxication in a Miniature Australian Shepherd dog].
Topics: Animals; Anthelmintics; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dog Diseases; Dogs; | 2012 |
Frequency of non-convulsive seizures and non-convulsive status epilepticus in subarachnoid hemorrhage patients in need of controlled ventilation and sedation.
Topics: Adolescent; Adult; Aged; Conscious Sedation; Critical Care; Electroencephalography; Female; Humans; | 2012 |
Treatment of status epilepticus: an international survey of experts.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Child; Consensus; Expert Testimony; Humans; Hyp | 2013 |
Sedative use in the last week of life and the implications for end-of-life decision making.
Topics: Adult; Aged; Anticonvulsants; Decision Making; Delirium; Double Effect Principle; Ethics, Clinical; | 2003 |
Review of the evidence for the use of propofol in the management of status epilepticus.
Topics: Anesthesia, General; Anticonvulsants; Cause of Death; Clinical Trials as Topic; Humans; Prognosis; P | 2003 |
Refractory status epilepticus.
Topics: Adult; Analgesics, Opioid; Anticonvulsants; Appendiceal Neoplasms; Barbiturates; Drug Therapy, Combi | 2004 |
[Therapeutic effect of intravenous anesthetic propofol on experimental model of status epilepticus].
Topics: Anesthetics, Intravenous; Animals; Brain; Disease Models, Animal; Electroencephalography; Glucose; M | 2004 |
Propofol treatment of refractory status epilepticus: a study of 31 episodes.
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Clonazepam; Coma; Dose-Response Relationship, Drug | 2004 |
Fatal propofol infusion syndrome in association with ketogenic diet.
Topics: Acidosis; Anticonvulsants; Child; Diet Therapy; Fatal Outcome; Humans; Infusions, Parenteral; Male; | 2004 |
Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus.
Topics: Adult; Anticonvulsants; Brain; Brain Edema; Coma; Drug Therapy; Fatal Outcome; Female; Humans; Hypno | 2004 |
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity.
Topics: Action Potentials; Animals; Anticonvulsants; Calcium Channels, L-Type; Frontal Lobe; In Vitro Techni | 2005 |
Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway?
Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Brain; Craniotomy; Dose-Response Relationship, Dr | 2005 |
Treatment with propofol: the new status quo for status epilepticus?
Topics: Adolescent; Anticonvulsants; Child; Clinical Trials as Topic; Drug Resistance; Humans; Meta-Analysis | 2005 |
[Management of status epilepticus].
Topics: Adult; Age Factors; Aged; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Diazepam; Dr | 2005 |
Propofol in the treatment of refractory status epilepticus.
Topics: Adult; Aged, 80 and over; Anticonvulsants; Electroencephalography; Female; Humans; Male; Middle Aged | 2006 |
[Case of amoxapine-induced refractory status epilepticus which was successfully treated with propofol].
Topics: Adult; Amoxapine; Anticonvulsants; Antidepressive Agents, Second-Generation; Female; Humans; Infusio | 2006 |
Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy.
Topics: Adult; Age Factors; Anesthesia, General; Anticonvulsants; Benzodiazepines; Humans; International Age | 2006 |
Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus.
Topics: Acidosis; Adult; Age Factors; Anticonvulsants; Cardiac Output, Low; Cardiomyopathies; Fatal Outcome; | 2007 |
AstraZeneca's response to the review by Wysowski and Pollock regarding deaths reported in association with propofol use.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Drug Industry; Humans; Intracranial Hypert | 2007 |
Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria.
Topics: Amines; Anesthetics, Intravenous; Anticonvulsants; Child; Comorbidity; Cyclohexanecarboxylic Acids; | 2008 |
Propofol for refractory status epilepticus.
Topics: Adult; Hemodynamics; Humans; Male; Propofol; Status Epilepticus | 1994 |
Propofol in the management of refractory status epilepticus: a case report.
Topics: Clonazepam; Coma; Drug Therapy, Combination; Electroencephalography; Glasgow Coma Scale; Humans; Inf | 1994 |
Management of status epilepticus.
Topics: Electroencephalography; Epilepsy, Complex Partial; Humans; Propofol; Status Epilepticus | 1994 |
[Effects of propofol in patients in status epilepticus of various origins. Electroencephalographic analysis].
Topics: Adult; Electroencephalography; Female; Humans; Male; Middle Aged; Propofol; Status Epilepticus | 1994 |
The management of status epilepticus with a continuous propofol infusion.
Topics: Adult; Female; Humans; Infusions, Intravenous; Propofol; Status Epilepticus; Time Factors | 1994 |
Generalized convulsive status epilepticus.
Topics: Adolescent; Adult; Aged; Anesthetics; Anticonvulsants; Benzodiazepines; Child; Epilepsy, Generalized | 1996 |
Propofol and midazolam in status epilepticus.
Topics: Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Midazolam; Propofol; Status Epile | 1996 |
Diagnosis and treatment of status epilepticus on a neurological intensive care unit.
Topics: Adolescent; Adult; Aged; Anesthetics; Anesthetics, Intravenous; Critical Care; Electrocardiography; | 1996 |
Treatment of convulsive status epilepticus with propofol: case report.
Topics: Adult; Anticonvulsants; Female; Humans; Infant; Propofol; Seizures; Status Epilepticus | 1997 |
The use of propofol to treat status epilepticus in a nine-month-old female patient.
Topics: Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Infant; Phenobarbital; Propofol; | 1998 |
Treatment of absence status in the Lennox-Gastaut syndrome with propofol.
Topics: Child; Electroencephalography; Epilepsy, Absence; Fetal Growth Retardation; Humans; Hypnotics and Se | 1998 |
Propofol in delirium tremens.
Topics: Alcohol Withdrawal Delirium; Diagnosis, Differential; Ethanol; Humans; Hypnotics and Sedatives; Male | 1998 |
Treatment of refractory complex-partial status epilepticus with propofol: case report.
Topics: Aged; Anticonvulsants; Drug Interactions; Drug Resistance, Multiple; Electroencephalography; Epileps | 2000 |
Re: Begemann et al. article describing the first case of nonconvulsive status epilepticus (NCSE) successfully treated with propofol.
Topics: Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy, Frontal Lobe; Fe | 2000 |
Propofol in subanesthetic doses terminates status epilepticus in a rodent model.
Topics: Animals; Disease Models, Animal; Electric Stimulation; Propofol; Rats; Rats, Sprague-Dawley; Status | 2001 |
Outcome of severe refractory status epilepticus in children.
Topics: Adolescent; Age Factors; Anesthetics, Intravenous; Anticonvulsants; Brain; Child; Child, Preschool; | 2001 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Propofol for resistant status epilepticus.
Topics: Adult; Anticonvulsants; Evidence-Based Medicine; Humans; Male; Propofol; Status Epilepticus | 2002 |
Propofol in myoclonus status epilepticus in comatose patients following cardiac resuscitation.
Topics: Adult; Aged; Anticonvulsants; Cardiopulmonary Resuscitation; Coma; Epilepsies, Myoclonic; Fatal Outc | 2002 |
[Status epilepticus following propofol anesthesia].
Topics: Adult; Anesthesia, Intravenous; Arthroscopy; Female; Humans; Knee Joint; Propofol; Status Epilepticu | 1992 |
Propofol anticonvulsant activity in experimental epileptic status.
Topics: Action Potentials; Animals; Cerebral Cortex; Disease Models, Animal; Electroencephalography; Male; P | 1992 |
[The use of propofol in status epilepticus].
Topics: Adult; Electroencephalography; Female; Humans; Propofol; Status Epilepticus | 1992 |
[The use of propofol in the treatment of convulsive status epilepticus: description of 2 cases].
Topics: Aged; Aged, 80 and over; Female; Humans; Middle Aged; Propofol; Status Epilepticus | 1991 |
Successful use of propofol in status epilepticus.
Topics: Aged; Female; Humans; Propofol; Status Epilepticus | 1990 |
Propofol infusion for control of status epilepticus.
Topics: Adult; Electroencephalography; Female; Humans; Infusions, Intravenous; Male; Propofol; Status Epilep | 1990 |
Propofol infusion for the treatment of status epilepticus.
Topics: Adult; Anticonvulsants; Female; Humans; Hypnotics and Sedatives; Phenols; Propofol; Status Epileptic | 1988 |
Propofol infusions for status epilepticus.
Topics: Adult; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Phenols; Propofol; Status Ep | 1988 |